Company: RPTX
Filing Date: 2025-11-17
Form Type: DEFA14A
Source: 0001193125-25-284040
Chunk: 60

Company: Repare Therapeutics Inc.
Filing Date: 2025-11-17
Form: DEFA14A
Chunk 60
---
 Company’s and its Subsidiary’s current       
 annual aggregate premium for directors’ and officers’ liability, fiduciary liability, and employment practices liability insurance policies currently maintained by the Company or its Subsidiary. If the Company for any reason fails, after      
 having used commercially reasonable efforts, to obtain such run off insurance policies as of the Effective Time, the Purchaser shall, or shall cause the Company and its Subsidiary to, maintain in effect for a period of at least six (6) years  
 from and after the Effective Time the directors’ and officers’ liability insurance in place as of the date hereof with terms, conditions, retentions and limits of liability that are no less advantageous to the present and former               
 directors and officers of the Company and its Subsidiary than the coverage provided under the Company’s and its Subsidiary’s existing policies as of the date hereof, or the Company shall purchase comparable directors’ and                      
 officers’ liability insurance for such six-(6) year period with terms, conditions, retentions and limits of liability that are at least as favourable to the present and former directors and officers of                                          
 the Company and its Subsidiary as provided in Company’s existing policies as of the date hereof; provided, that, the annual premium for such directors’ and officers’ liability insurance policy may not be in excess of 300% of the               
 Company’s and its Subsidiary’s current annual aggregate premium for directors’ and officers’ liability, fiduciary liability, and employment practices liability insurance policies currently maintained by the Company or its                      
 Subsidiary.                                                                                                                                                                                                                                        |

| (c) | If the Company or the Subsidiary or any of their respective successors or assigns (a) consolidates or                                                                                                                                              
 amalgamates with, or merges or liquidates into, any other person and is not a continuing or surviving company or entity of such consolidation, amalgamation, merger, amalgamation or liquidation, or (b) transfers all or substantially all of its 
 properties and assets to any person, the Purchaser shall ensure that any such successor or assign (including, as applicable, any acquirer of substantially all of the properties and assets of the Company or its Subsidiary) assumes all of the   
 obligations set forth in this Section 5.8.                                                                                                                                                                                                         |

- 34 -

| 5.9 | Nasdaq Delisting |

Subject to applicable Law, each of the Company and the Purchaser agrees